① The three major US stock index futures had mixed ups and downs: Dow futures fell 0.16%, S&P 500 futures rose 0.12%, and NASDAQ futures rose 0.52%. ② The German DAX index rose 0.10%, the British FTSE 100 index rose 0.21%, the French CAC40 index fell 0.13%, and the European Stoxx 50 index rose 0.30%. ③ WTI crude oil rose 0.48% to $81.64 per barrel. Brent crude rose 0.18% to $87.23 per barrel. ④ Goldman Sachs: The market's bets on the Fed's policy are still too hawkish, and the rate hike in September is “very unlikely”. ⑤ Big Ma and Little Mozi look at S&P's 8,000 points, and the violent counterattack of semiconductors and the Korean stock market verifies that “profit owners are rising.” ⑥ Shipping in the Strait of Hormuz has almost come to a standstill, and Iran says it is drawing up a sea route plan with Oman. ⑦ Snap's US stock fell 4.6% in the premarket, having previously fallen by more than 16%. ⑧ EyePoint's stock price plummeted by more than 69% before the market, as the company's eye medicine fell short of its main target in later trials. ⑨ Astera Labs' stock price rose nearly 5% before the market, after Northland Capital raised its rating to “outperform the market.”

① The three major US stock index futures had mixed ups and downs: Dow futures fell 0.16%, S&P 500 futures rose 0.12%, and NASDAQ futures rose 0.52%. ② The German DAX index rose 0.10%, the British FTSE 100 index rose 0.21%, the French CAC40 index fell 0.13%, and the European Stoxx 50 index rose 0.30%. ③ WTI crude oil rose 0.48% to $81.64 per barrel. Brent crude rose 0.18% to $87.23 per barrel. ④ Goldman Sachs: The market's bets on the Fed's policy are still too hawkish, and the rate hike in September is “very unlikely”. ⑤ Big Ma and Little Mozi look at S&P's 8,000 points, and the violent counterattack of semiconductors and the Korean stock market verifies that “profit owners are rising.” ⑥ Shipping in the Strait of Hormuz has almost come to a standstill, and Iran says it is drawing up a sea route plan with Oman. ⑦ Snap's US stock fell 4.6% in the premarket, having previously fallen by more than 16%. ⑧ EyePoint's stock price plummeted by more than 69% before the market, as the company's eye medicine fell short of its main target in later trials. ⑨ Astera Labs' stock price rose nearly 5% before the market, after Northland Capital raised its rating to “outperform the market.”